Systems toxicology to support development of adverse outcome pathways

被引：0
|
作者：
Grafstrom, R. C. [1 ,2 ]
Hongisto, V. [2 ]
Kohonen, P. J. [1 ,2 ]
Nymark, P. [1 ,2 ]
机构：
[1] Karolinska Inst, Environm Med, Stockholm, Sweden
[2] MIsvik Biol, Div Toxicol, Turku, Finland
来源：
TOXICOLOGY LETTERS | 2019年 / 314卷
关键词：
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
S07-04
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [41] Using AOP-Wiki to support the ecotoxicological risk assessment of nanomaterials: first steps in the development of novel adverse outcome pathways
    Jagiello, Karolina
    Judzinska, Beata
    Sosnowska, Anita
    Lynch, Iseult
    Halappanavar, Sabina
    Puzyn, Tomasz
    ENVIRONMENTAL SCIENCE-NANO, 2022, 9 (05) : 1675 - 1684
  • [42] Adverse outcome pathways: hype or hope?
    Vinken, Mathieu
    Whelan, Maurice
    Rogiers, Vera
    ARCHIVES OF TOXICOLOGY, 2014, 88 (01) : 1 - 2
  • [43] Pathways of Number Line Development in Children Predictors and Risk for Adverse Mathematical Outcome
    Friso-van den Bos, Ilona
    Van Luit, Johannes E. H.
    Kroesbergen, Evelyn H.
    Xenidou-Dervou, Iro
    Van Lieshout, Ernest C. D. M.
    Van der Schoot, Menno
    Jonkman, Lisa M.
    ZEITSCHRIFT FUR PSYCHOLOGIE-JOURNAL OF PSYCHOLOGY, 2015, 223 (02): : 120 - 128
  • [44] Applying Evidence-Based Methods to the Development and Use of Adverse Outcome Pathways
    de Vries, Rob B. M.
    Angrish, Michelle
    Browne, Patience
    Brozek, Jan
    Rooney, Andrew A.
    Wikoff, Daniele S.
    Whaley, Paul
    Edwards, Stephen W.
    Morgan, Rebecca L.
    Druwe, Ingrid L.
    Hoffmann, Sebastian
    Hartung, Thomas
    Thayer, Kristina
    Avey, Marc T.
    Beverly, Brandiese E. J.
    Falavigna, Maicon
    Gibbons, Catherine
    Goyak, Katy
    Kraft, Andrew
    Nampo, Fernando
    Qaseem, Amir
    Sears, Meg
    Singh, Jasvinder A.
    Willett, Catherine
    Yost, Erin Y.
    Schunemann, Holger
    Tsaioun, Katya
    ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2021, 38 (02) : 336 - 347
  • [45] The development of adverse outcome pathways for mutagenic effects for the organization for economic co-operation and development
    Yauk, Carole L.
    Bishop, Jack
    Dearfield, Kerry L.
    Douglas, George R.
    Hales, Barbara F.
    Luijten, Mirjam
    O'Brien, Jason M.
    Robaire, Bernard
    Sram, Radim
    van Benthem, Jan
    Wade, Mike G.
    White, Paul A.
    Marchetti, Francesco
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2013, 54 (02) : 79 - 81
  • [46] Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes
    Patlewicz, Grace
    Simon, Ted W.
    Rowlands, J. Craig
    Budinsky, Robert A.
    Becker, Richard A.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2015, 71 (03) : 463 - 477
  • [47] Using adverse outcome pathways (AOPs) to support tiered-testing strategies for toxicity assessment
    Paini, A.
    TOXICOLOGY LETTERS, 2022, 368 : S69 - S69
  • [48] Elucidating adverse outcome pathways with phenotypic data from primary human cell systems
    Berg, Ellen
    Polokoff, Mark
    O'Mahony, Alison
    Yang, Jian
    TOXICOLOGY LETTERS, 2014, 229 : S55 - S55
  • [49] TOXICOGENOMICS AND SYSTEMS TOXICOLOGY APPROACHES TO UNDERSTANDING ADVERSE OUTCOMES
    Willy, Jeffrey
    Qiu, Jiabin
    Wang, Evan
    Webster, Yue
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S8 - S8
  • [50] Creating Quantitative Adverse Outcome Pathways with Effectopedia
    Aladjov, H. T.
    TOXICOLOGY LETTERS, 2018, 295 : S11 - S11
12345